EORTC protocol 24872

Randomized phase III trial of methotrexate vs 10-EdAm, a new methotrexate analogue,in patients with advanced squamous cell carcinoma of the head and neck
Trial StatusAll trial activities ended
DatesDate of activation: 15-Mar-88
Closed on : 19-Feb-92
Data management at EORTCFull
Phase2
Randomized trialYes
TypeAdvanced
Targeted Sample size40
Number of steps1
Drug
Study StaffJan Herman Schornagel (Study Coordinator) - The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section